Novartis AG
NVSNYSEPharmaceutical PreparationsFiscal year ends December 31Also trades as NVSEF
$160.79−0.31 (-0.19%)
Close on Oct 30, 2026Market cap $306.81BP/E 22.5Yield –
Novartis Treasury Share Repurchases Cash Outflow by Year
Treasury Share Repurchases Cash Outflow ($M)
Novartis Treasury Share Repurchases Cash Outflow: $9,212M in FY2025, up 10.6% from a year earlier.
Latest, FY2025
9,212
Period ended Dec 31, 2025
Change on a year earlier
+10.6%
8,331 in FY2024
History
10 years
Since FY2016
Sources
9
Documents cited below
Where the FY2025 figure comes from
“|| Purchases of treasury shares | -9 212 | -8 331”
Source: Novartis Form 6-K (0001114448-26-000007) ↗
Reported in Form 6-K Cash Flow & Form 20-F.
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Treasury Share Repurchases Cash Outflow ($M) | Year on year | Source |
|---|---|---|---|---|
| FY2025 | Dec 31, 2025 | 9,212 | +10.6% | Novartis Form 6-K (0001114448-26-000007) ↗ |
| FY2024 | Dec 31, 2024 | 8,331 | -4.5% | Novartis Form 6-K (0001114448-26-000007) ↗ |
| FY2023 | Dec 31, 2023 | 8,719 | -18.1% | Novartis Form 6-K (0001370368-25-000007) ↗ |
| FY2022 | Dec 31, 2022 | 10,652 | +248.4% | Novartis Form 6-K (0001370368-24-000007) ↗ |
| FY2021 | Dec 31, 2021 | 3,057 | +7.6% | Novartis Form 20-F (0001370368-24-000004) ↗ |
| FY2020 | Dec 31, 2020 | 2,842 | -48.6% | Novartis Form 20-F/A (0001370368-23-000048) ↗ |
| FY2019 | Dec 31, 2019 | 5,533 | +171.8% | Novartis Form 20-F (0001370368-22-000010) ↗ |
| FY2018 | Dec 31, 2018 | 2,036 | -62.9% | Novartis Form 20-F (0001370368-21-000006) ↗ |
| FY2017 | Dec 31, 2017 | 5,490 | +395.0% | Novartis Form 20-F (0001370368-20-000003) ↗ |
| FY2016 | Dec 31, 2016 | 1,109 | – | Novartis Form 20-F (0001370368-19-000002) ↗ |
Cite this data
StockData. (2026). Novartis Treasury Share Repurchases Cash Outflow ($M), annual FY2016–FY2025 [Data set]. Compiled from Novartis SEC filings and investor materials. https://stockdatahq.com/stocks/nvs/kpis/cf-buyback-quarterly-usd
See every metric in the Novartis KPI table. Data updated Nov 2, 2026.